Liver transplant recipients gain up to 17 life-years from living donors vs. donor waitlist

A case-control study in JAMA Surgery revealed that patients with end-stage liver disease had a 34% reduction in mortality after living-donor liver transplantation compared with patients who remained on a wait list for a deceased donor.Researchers wrote that the survival benefit of living-donor liver transplantation (LDLT), especially in patients with low MELD incorporating sodium levels (MELD-Na) scores, is “remarkable,” as previously published studies with deceased donors noted that such benefits occurred in patients with scores of 15 or higher.“This study’s findingsRead More

Generated by Feedzy